| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.0001 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.86 | 0.0004 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |